Abstract
Tissue regeneration following myocardial infarction (MI) represents a major challenge in cardiovascular therapy, as current clinical approaches are limited in their ability to regenerate or replace damaged myocardium. The lack of clinically-relevant cell sources, and the growing importance of paracrine effects of cell therapy, mediated by soluble growth factors and cytokines, favors the use of acellular biomaterials for myocardial tissue engineering. While the efficacy of acellular scaffold-based approaches have already been shown, applying the biomaterial in an injectable form represents a more clinically-appealing strategy, where only minimally invasive interventions are required to deliver the biopolymer solution. However, in order to enhance the passive effects mediated by the injected biomaterial on infarct stabilization and mechanical support, and achieve long-term functional improvement and regeneration of the cardiac muscle, the combination with controlled spatio-temporal delivery of bioactive molecules is required. Biomaterial-based growth factor delivery has already been shown to improve therapeutic outcome after MI. Affinity-binding alginate represents an example of such a system. This strategy has promising potential for myocardial repair and regeneration, as it provides mechanical support conferred by in situ hydrogel formation, and can affect multiple processes of myocardial regeneration by controlled delivery of multiple proteins. In conclusion, as the development of novel polymer schemes and approaches continues, the application of biomaterials that can instruct a favorable tissue reconstruction, facilitate self-repair, tissue salvage and regeneration, represents a platform for future modifications and combinations (for instance, with cell therapy). Hopefully, such efforts will have major clinical consequences on the treatment of MI and improve long-term outcome in heart failure patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbate, A., Bussani, R., Amin, M.S., Vetrovec, G.W., Baldi, A.: Acute myocardial infarction and heart failure: role of apoptosis. Int. J. Biochem. Cell Biol. 38(11), 1834–1840 (2006)
Abdel-Latif, A., Bolli, R., Zuba-Surma, E.K., Tleyjeh, I.M., Hornung, C.A., Dawn, B.: Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 156(2), 216–226 (2008)
Ahuja, P., Sdek, P., MacLellan, W.R.: Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87(2), 521–544 (2007)
Akhyari, P., Kamiya, H., Haverich, A., Karck, M., Lichtenberg, A.: Myocardial tissue engineering: the extracellular matrix. Eur. J. Cardiothorac. Surg. 34(2), 229–241 (2008)
Al-Shamkhani, A., Duncan, R.: Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in vivo. J. Bioactive Compat. Polym. 10(1), 4–13 (1995)
Beohar, N., Rapp, J., Pandya, S., Losordo, D.W.: Rebuilding the damaged heart the potential of cytokines and growth factors in the treatment of ischemic heart disease. J. Am. Coll. Cardiol. 56(16), 1287–1297 (2010)
Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., Jovinge, S., Frisen, J.: Evidence for cardiomyocyte renewal in humans. Science 324(5923), 98–102 (2009)
Bersell, K., Arab, S., Haring, B., Kuhn, B.: Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138(2), 257–270 (2009)
Bock-Marquette, I., Saxena, A., White, M.D., Michael DiMaio, J., Srivastava, D.: Thymosin [beta]4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016), 466–472 (2004)
Boersma, E., Mercado, N., Poldermans, D., Gardien, M., Vos, J., Simoons, M.L.: Acute myocardial infarction. Lancet 361(9360), 847–858 (2003)
Bollini, S., Smart, N., Riley, P.R.: Resident cardiac progenitor cells: at the heart of regeneration. J. Mol. Cell. Cardiol. (2010). doi:10.1016/j.yjmcc.2010.07.006
Bougioukas, I., Didilis, V., Ypsilantis, P., Giatromanolaki, A., Sivridis, E., Lialiaris, T., Mikroulis, D., Simopoulos, C., Bougioukas, G.: Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium. Cardiovasc. Pathol. 16(2), 63–68 (2007)
Callegari, A., Bollini, S., Iop, L., Chiavegato, A., Torregrossa, G., Pozzobon, M., Gerosa, G., De Coppi, P., Elvassore, N., Sartore, S.: Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 28(36), 5449–5461 (2007)
Campa, V.M., Gutierrez-Lanza, R., Cerignoli, F., Diaz-Trelles, R., Nelson, B., Tsuji, T., Barcova, M., Jiang, W., Mercola, M.: Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J. Cell Biol. 183(1), 129–141 (2008)
Carmeliet, P.: Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6(4), 389–395 (2000)
Chavakis, E., Koyanagi, M., Dimmeler, S.: Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 121(2), 325–335 (2010)
Christman, K.L., Fok, H.H., Sievers, R.E., Fang, Q., Lee, R.J.: Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10(3–4), 403–409 (2004)
Christman, K.L., Lee, R.J.: Biomaterials for the treatment of myocardial infarction. J. Am. Coll. Cardiol. 48(5), 907–913 (2006)
Christman, K.L., Vardanian, A.J., Fang, Q., Sievers, R.E., Fok, H.H., Lee, R.J.: Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44(3), 654–660 (2004)
Conti, E., Carrozza, C., Capoluongo, E., Volpe, M., Crea, F., Zuppi, C., Andreotti, F.: Insulin-like growth factor-1 as a vascular protective factor. Circulation 110, 2260–2265 (2004)
Dai, W., Wold, L.E., Dow, J.S., Kloner, R.A.: Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol. 46(4), 714–719 (2005)
Davani, E.Y., Brumme, Z., Singhera, G.K., Cote, H.C.F., Harrigan, P.R., Dorscheid, D.R.: Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. Critical Care 7, 176–183 (2003)
Davis, M.E., Hsieh, P.C., Grodzinsky, A.J., Lee, R.T.: Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 97(1), 8–15 (2005)
Davis, M.E., Hsieh, P.C., Takahashi, T., Song, Q., Zhang, S., Kamm, R.D., Grodzinsky, A.J., Anversa, P., Lee, R.T.: Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl. Acad. Sci. USA 103(21), 8155–8160 (2006)
Dimmeler, S., Burchfield, J., Zeiher, A.M.: Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28(2), 208–216 (2008)
Dobaczewski, M., Gonzalez-Quesada, C., Frangogiannis, N.G.: The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 48(3), 504–511 (2010)
Dorn 2nd, G.W.: Periostin and myocardial repair, regeneration, and recovery. N. Engl. J. Med. 357(15), 1552–1554 (2007)
Dvir, T., Kedem, A., Ruvinov, E., Levy, O., Freeman, I., Landa, N., Holbova, R., Feinberg, M.S., Dror, S., Etzion, Y., Leor, J., Cohen, S.: Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl. Acad. Sci. USA 106(35), 14990–14995 (2009)
Eitan, Y., Sarig, U., Dahan, N., Machluf, M.: Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling and biocompatibility. Tissue Eng. C Methods 16(4), 671–683 (2009)
Ferrarini, M., Arsic, N., Recchia, F.A., Zentilin, L., Zacchigna, S., Xu, X., Linke, A., Giacca, M., Hintze, T.H.: Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ. Res. 98(7), 954–961 (2006)
Frangogiannis, N.G., Smith, C.W., Entman, M.L.: The inflammatory response in myocardial infarction. Cardiovasc. Res. 53(1), 31–47 (2002)
Frantz, S., Bauersachs, J., Ertl, G.: Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc. Res. 81(3), 474–481 (2009)
Freeman, I., Cohen, S.: The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 30(11), 2122–2131 (2009)
Freeman, I., Kedem, A., Cohen, S.: The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29(22), 3260–3268 (2008)
Fujimoto, K.L., Tobita, K., Merryman, W.D., Guan, J., Momoi, N., Stolz, D.B., Sacks, M.S., Keller, B.B., Wagner, W.R.: An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J. Am. Coll. Cardiol. 49(23), 2292–2300 (2007)
Gaballa, M.A., Sunkomat, J.N., Thai, H., Morkin, E., Ewy, G., Goldman, S.: Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J. Heart Lung Transplant. 25(8), 946–954 (2006)
Garg, S., Narula, J., Chandrashekhar, Y.: Apoptosis and heart failure: clinical relevance and therapeutic target. J. Mol. Cell. Cardiol. 38(1), 73–79 (2005)
Gaudette, G.R., Cohen, I.S.: Cardiac regeneration: materials can improve the passive properties of myocardium, but cell therapy must do more. Circulation 114(24), 2575–2577 (2006)
Gnecchi, M., Zhang, Z., Ni, A., Dzau, V.J.: Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103(11), 1204–1219 (2008)
Haider, H., Akbar, S.A., Ashraf, M.: Angiomyogenesis for myocardial repair. Antioxid. Redox Signal. 11(8), 1929–1944 (2009)
Hansson, E.M., Lindsay, M.E., Chien, K.R.: Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 5(4), 364–377 (2009)
Hao, X., Silva, E.A., Mansson-Broberg, A., Grinnemo, K.H., Siddiqui, A.J., Dellgren, G., Wardell, E., Brodin, L.A., Mooney, D.J., Sylven, C.: Angiogenic effects of sequential release of VEGF-A(165) and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc. Res. 75(1), 178–185 (2007)
Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K., Komuro, I.: G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11(3), 305–311 (2005)
Hassink, R.J., Pasumarthi, K.B., Nakajima, H., Rubart, M., Soonpaa, M.H., de la Riviere, A.B., Doevendans, P.A., Field, L.J.: Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78(1), 18–25 (2008)
Hausenloy, D.J., Yellon, D.M.: Cardioprotective growth factors. Cardiovasc. Res. 83(2), 179–194 (2009)
Hiasa, K., Ishibashi, M., Ohtani, K., Inoue, S., Zhao, Q., Kitamoto, S., Sata, M., Ichiki, T., Takeshita, A., Egashira, K.: Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109(20), 2454–2461 (2004)
Hsieh, P.C., Davis, M.E., Gannon, J., MacGillivray, C., Lee, R.T.: Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116(1), 237–248 (2006)
Hsieh, P.C., Segers, V.F., Davis, M.E., MacGillivray, C., Gannon, J., Molkentin, J.D., Robbins, J., Lee, R.T.: Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13(8), 970–974 (2007)
Hsieh, P.C.H., Davis, M.E., Gannon, J., MacGillivray, C., Lee, R.T.: Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116, 237–248 (2006)
Hsieh, P.C.H., MacGillivray, C., Gannon, J., Cruz, F.U., Lee, R.T.: Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 114, 637–644 (2006)
Hu, X., Dai, S., Wu, W.J., Tan, W., Zhu, X., Mu, J., Guo, Y., Bolli, R., Rokosh, G.: Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116(6), 654–663 (2007)
Iwakura, A., Fujita, M., Kataoka, K., Tambara, K., Sakakibara, Y., Komeda, M., Tabata, Y.: Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18(2), 93–99 (2003)
Jayasankar, V., Woo, Y.J., Bish, L.T., Pirolli, T.J., Chatterjee, S., Berry, MF., Burdick, J., Gardner, T.J., Sweeney, H.L.: Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108(Suppl 1), II230–II236 (2003)
Jayasankar, V., Woo, Y.J., Pirolli, T.J., Bish, L.T., Berry, M.F., Burdick, J., Gardner, T.J., Sweeney, H.L.: Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J. Card. Surg. 20, 93–101 (2005)
Jopling, C., Sleep, E., Raya, M., Marti, M., Raya, A., Belmonte, J.C.: Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464(7288), 606–609 (2010)
Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., Ogorek, B., Ferreira-Martins, J., Goichberg, P., Rondon-Clavo, C., Sanada, F., D’Amario, D., Rota, M., Del Monte, F., Orlic, D., Tisdale, J., Leri, A., Anversa, P.: Cardiomyogenesis in the adult human heart. Circ. Res. 107(2), 305–315 (2010)
Kobayashi, H., Minatoguchi, S., Yasuda, S., Bao, N., Kawamura, I., Iwasa, M., Yamaki, T., Sumi, S., Misao, Y., Ushikoshi, H., Nishigaki, K., Takemura, G., Fujiwara, T., Tabata, Y., Fujiwara, H.: Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair. Cardiovasc. Res. 79(4), 611–620 (2008)
Kochupura, P.V., Azeloglu, E.U., Kelly, D.J., Doronin, S.V., Badylak, S.F., Krukenkamp, I.B., Cohen, I.S., Gaudette, G.R.: Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112(9 Suppl), I144–I149 (2005)
Kondo, I., Ohmori, K., Oshita, A., Takeuchi, H., Fuke, S., Shinomiya, K., Noma, T., Namba, T., Kohno, M.: Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44(3), 644–653 (2004)
Kuhn, B., del Monte, F., Hajjar, R.J., Chang, Y.S., Lebeche, D., Arab, S., Keating, M.T.: Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 13(8), 962–969 (2007)
Laflamme, M.A., Zbinden, S., Epstein, S.E., Murry, C.E.: Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2, 307–339 (2007)
Landa, N., Miller, L., Feinberg, M.S., Holbova, R., Shachar, M., Freeman, I., Cohen, S., Leor, J.: Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117(11), 1388–1396 (2008)
Leask, A.: TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc. Res. 74(2), 207–212 (2007)
Lee, T.M., Chen, C.C., Chang, N.C.: Granulocyte colony-stimulating factor increases sympathetic reinnervation and the arrhythmogenic response to programmed electrical stimulation after myocardial infarction in rats. Am. J. Physiol. 297(2), H512–H522 (2009)
Leor, J., Tuvia, S., Guetta, V., Manczur, F., Castel, D., Willenz, U., Petnehazy, O., Landa, N., Feinberg, M.S., Konen, E., Goitein, O., Tsur-Gang, O., Shaul, M., Klapper, L., Cohen, S.: Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J. Am. Coll. Cardiol. 54(11), 1014–1023 (2009)
Li, Q., Li, B., Wang, X., Leri, A., Jana, K.P., Liu, y., Kajstura, J., Baserga, R., Anversa, P.: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100, 1991–1999 (1997)
Li, Q., Li, B., Wang, X., Leri, A., Jana, K.P., Liu, Y., Kajstura, J., Baserga, R., Anversa, P.: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100(8), 1991–1999 (1997)
Liao, S., Porter, D., Scott, A., Newman, G., Doetschman, T., Schultz Jel, J.: The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. J. Mol. Cell. Cardiol. 42(1), 106–120 (2007)
Linke, A., Muller, P., Nurzynska, D., Casarsa, C., Torella, D., Nasclimbene, A., Castaldo, C., Cascapera, S., Bohm, M., Quaini, F., Urbanek, K., Leri, A., Hintze, T.H., Kajstura, J., Anversa, P.: Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. PNAS 102, 8966–8971 (2005)
Liu, Y., Sun, L., Huan, Y., Zhao, H., Deng, J.: Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur. J. Cardiothorac. Surg. 30(1), 103–107 (2006)
Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, P.M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M.M., Meigs, J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V.L., Rosamond, W., Sacco, R., Sorlie, P., Thom, T., Wasserthiel-Smoller, S., Wong, N.D., Wylie-Rosett, J.: Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 121(7), e46–e215 (2010)
Lu, H., Xu, X., Zhang, M., Cao, R., Brakenhielm, E., Li, C., Lin, H., Yao, G., Sun, H., Qi, L., Tang, M., Dai, H., Zhang, Y., Su, R., Bi, Y., Cao, Y.: Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc. Natl. Acad. Sci. USA 104(29), 12140–12145 (2007)
Masuda, S., Shimizu, T., Yamato, M., Okano, T.: Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 60(2), 277–285 (2008)
McMurray, J.J.: Clinical practice. Systolic heart failure. N. Engl. J. Med. 362(3), 228–238 (2010)
Menasche, P.: Cardiac cell therapy: lessons from clinical trials. J. Mol. Cell. Cardiol. (2010) doi:10.1016/j.yjmcc.2010.06.010
Mirotsou, M., Jayawardena, T.M., Schmeckpeper, J., Gnecchi, M., Dzau, V.J.: Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mo.l Cell. Cardiol. (2010). doi:10.1016/j.yjmcc.2010.08.005
Mukherjee, R., Zavadzkas, J.A., Saunders, S.M., McLean, J.E., Jeffords, L.B., Beck, C., Stroud, R.E., Leone, A.M., Koval, C.N., Rivers, W.T., Basu, S., Sheehy, A., Michal, G., Spinale, F.G.: Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann. Thorac. Surg. 86(4), 1268–1276 (2008)
Nakajima, H., Sakakibara, Y., Tambara, K., Iwakura, A., Doi, K., Marui, A., Ueyama, K., Ikeda, T., Tabata, Y., Komeda, M.: Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness. J. Artif. Organs. 7(2), 58–61 (2004)
Nakamura, T., Matsumoto, K., Mizuno, S., Sawa, Y., Matsuda, H.: Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am. J. Physiol. 288(5), H2131–H2139 (2005)
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., Nakamura, T.: Myoardial protection from ischemia/reperfusion injury by endogenous and exogenous. HGF J. Clin. Invest. 106, 1511–1519 (2000)
Nian, M., Lee, P., Khaper, N., Liu, P.: Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94(12), 1543–1553 (2004)
Novoyatleva, T., Diehl, F., van Amerongen, M.J., Patra, C., Ferrazzi, F., Bellazzi, R., Engel, F.B.: TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc. Res. 85(4), 681–690 (2010)
Ota, T., Gilbert, T.W., Schwartzman, D., McTiernan, C.F., Kitajima, T., Ito, Y., Sawa, Y., Badylak, S.F., Zenati, M.A.: A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladder matrix. J. Thorac. Cardiovasc. Surg. 136(5), 1309–1317 (2008)
Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., Taylor, D.A.: Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med. 14(2), 213–221 (2008)
Parmacek, M.S., Epstein, J.A.: Cardiomyocyte renewal. N. Engl. J. Med. 361(1), 86–88 (2009)
Parsa, C.J., Matsumoto, A., Kim, J., Riel, R.U., Pascal, L.S., Walton, G.B., Thompson, R.B., Petrofski, J.A., Annex, B.H., Stamler, J.S., Koch, W.J.: A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112(7), 999–1007 (2003)
Pasumarthi, K.B., Field, L.J.: Cardiomyocyte cell cycle regulation. Circ. Res. 90(10), 1044–1054 (2002)
Pikkarainen, S., Tokola, H., Kerkela, R., Ruskoaho, H.: GATA transcription factors in the developing and adult heart. Cardiovasc. Res. 63(2), 196–207 (2004)
Ren, J., Samson, W.K., Sowers, J.R.: Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell. Cardiol. 31, 2049–2061 (1999)
Renault, M.A., Losordo, D.W.: Therapeutic myocardial angiogenesis. Microvasc. Res. 74(2–3), 159–171 (2007)
Richardson, T.P., Peters, M.C., Ennett, A.B., Mooney, D.J.: Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19(11), 1029–1034 (2001)
Risau, W.: Mechanisms of angiogenesis. Nature 386(6626), 671–674 (1997)
Robinson, K.A., Li, J., Mathison, M., Redkar, A., Cui, J., Chronos, N.A., Matheny, R.G., Badylak, S.F.: Extracellular matrix scaffold for cardiac repair. Circulation 112(9 Suppl), I135–I143 (2005)
Ruvinov, E., Dvir, T., Leor, J., Cohen, S.: Myocardial repair: from salvage to tissue reconstruction. Expert Rev. Cardiovasc. Ther. 6(5), 669–686 (2008)
Ruvinov, E., Leor, J., Cohen, S.: The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31(16), 4573–4582 (2010)
Ruvinov, E., Leor, J., Cohen, S.: The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32(2), 565–578 (2011)
Rysa, J., Tenhunen, O., Serpi, R., Soini, Y., Nemer, M., Leskinen, H., Ruskoaho, H.: GATA-4 is an angiogenic survival factor of the infarcted heart. Circ. Heart Fail 3(3), 440–450 (2010)
Segers, V.F., Lee, R.T.: Local delivery of proteins and the use of self-assembling peptides. Drug discovery today 12(13–14), 561–568 (2007)
Segers, V.F., Lee, R.T.: Stem-cell therapy for cardiac disease. Nature 451(7181), 937–942 (2008)
Segers, V.F., Tokunou, T., Higgins, L.J., MacGillivray, C., Gannon, J., Lee, R.T.: Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116(15), 1683–1692 (2007)
Shapiro, L., Cohen, S.: Novel alginate sponges for cell culture and transplantation. Biomaterials 18(8), 583–590 (1997)
Shimizu, T., Yamato, M., Kikuchi, A., Okano, T.: Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24(13), 2309–2316 (2003)
Shriver, Z., Liu, D., Sasisekharan, R.: Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc. Med. 12(2), 71–77 (2002)
Smart, N., Risebro, C.A., Melville, A.A., Moses, K., Schwartz, R.J., Chien, K.R., Riley, P.R.: Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445(7124), 177–182 (2007)
Suleiman, M.S., Singh, R.J., Stewart, C.E.: Apoptosis and the cardiac action of insulin-like growth factor I. Pharmacol. Ther. 114(3), 278–294 (2007)
Tabata, Y., Ikada, Y.: Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20(22), 2169–2175 (1999)
Takano, H., Ueda, K., Hasegawa, H., Komuro, I.: G-CSF therapy for acute myocardial infarction. Trends Pharmacol. Sci. 28(10), 512–517 (2007)
Takehara, N., Tsutsumi, Y., Tateishi, K., Ogata, T., Tanaka, H., Ueyama, T., Takahashi, T., Takamatsu, T., Fukushima, M., Komeda, M., Yamagishi, M., Yaku, H., Tabata, Y., Matsubara, H., Oh, H.: Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J. Am. Coll. Cardiol. 52(23), 1858–1865 (2008)
Tomanek, R.J., Zheng, W., Yue, X.: Growth factor activation in myocardial vascularization: therapeutic implications. Mol. Cell. Biochem. 264(1–2), 3–11 (2004)
Tomita, N., Morishita, R., Taniyama, Y., Koike, H., Aoki, M., Shimizu, H., Matsumoto, K., Nakamura, T., Kaneda, Y., Ogihara, T.: Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107(10), 1411–1417 (2003)
Torella, D., Rota, M., Nurzinska, D., Musso, E., Monsen, A., Shiraishi, I., Zias, E., Walsh, K., Rozenzweig, A., Sussman, M.A., Urbanek, K., Nadal-Ginard, B., Kajstura, J., Anversa, P., Leri, A.: Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94, 514–524 (2004)
Tsur-Gang, O., Ruvinov, E., Landa, N., Holbova, R., Feinberg, M.S., Leor, J., Cohen, S.: The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 30(2), 189–195 (2009)
Ueda, H., Nakamura, T., Matsumoto, K., Sawa, Y., Matsuda, H., Nakamura, T.: A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc. Res. 51, 41–50 (2001)
Urbanek, K., Rota, M., Cascapera, S., Bearzi, C., Nascimbene, A., De Angelis, A., Hosoda, T., Chimenti, S., Baker, M., Limana, F., Nurzynska, D., Torella, D., Rotatori, F., Rastaldo, R., Musso, E., Quaini, F., Leri, A., Kajstura, J., Anversa, P.: Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97(7), 663–673 (2005)
van der Meer, P., Lipsic, E., Henning, R.H., Boddeus, K., van der Velden, J., Voors, A.A., van Veldhuisen, D.J., van Gilst, W.H., Schoemaker, R.G.: Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J. Am. Coll. Cardiol. 46(1), 125–133 (2005)
Vandervelde, S., van Luyn, M.J., Tio, R.A., Harmsen, M.C.: Signaling factors in stem cell-mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39(2), 363–376 (2005)
Vanhoutte, D., Schellings, M., Pinto, Y., Heymans, S.: Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc. Res. 69(3), 604–613 (2006)
Vera Janavel, G., Crottogini, A., Cabeza Meckert, P., Cuniberti, L., Mele, A., Papouchado, M., Fernandez, N., Bercovich, A., Criscuolo, M., Melo, C., Laguens, R.: Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther. 13(15), 1133–1142 (2006)
Vesely, I.: Heart valve tissue engineering. Circ. Res. 97(8), 743–755 (2005)
Wainwright, J.M., Czajka, C.A., Patel, U.B., Freytes, D.O., Tobita, K., Gilbert, T.W., Badylak, S.F.: Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng. C Methods 16(3), 525–532 (2009)
Wall, S.T., Walker, J.C., Healy, K.E., Ratcliffe, M.B., Guccione, J.M.: Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114(24), 2627–2635 (2006)
Wang, T., Wu, D.Q., Jiang, X.J., Zhang, X.Z., Li, X.Y., Zhang, J.F., Zheng, Z.B., Zhuo, R., Jiang, H., Huang, C.: Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur. J. Heart Fail. 11(1), 14–19 (2009)
Wang, Y., Ahmad, N., Wani, M.A., Ashraf, M.: Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 37, 1041–1052 (2004)
Wang, Y., Ahmad, N., Wani, M.A., Ashraf, M.: Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 37(5), 1041–1052 (2004)
Webster, K.A.: Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol. Sci. 28(9), 492–499 (2007)
World Health Organization: The atlas of heart disease and stroke. http://wwwwhoint/cardiovascular_diseases/resources/atlas/en/
Yu, J., Christman, K.L., Chin, E., Sievers, R.E., Saeed, M., Lee, R.J.: Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 137(1), 180–187 (2009)
Zhang, G., Nakamura, Y., Wang, X., Hu, Q., Suggs, L.J., Zhang, J.: Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng. 13(8), 2063–2071 (2007)
Zmora, S., Glicklis, R., Cohen, S.: Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials 23(20), 4087–4094 (2002)
Zohlnhofer, D., Dibra, A., Koppara, T., de Waha, A., Ripa, R.S., Kastrup, J., Valgimigli, M., Schomig, A., Kastrati, A.: Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 51(15), 1429–1437 (2008)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ruvinov, E., Cohen, S. (2011). Instructive Biomaterials for Myocardial Regeneration and Repair. In: Zilberman, M. (eds) Active Implants and Scaffolds for Tissue Regeneration. Studies in Mechanobiology, Tissue Engineering and Biomaterials, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8415_2010_53
Download citation
DOI: https://doi.org/10.1007/8415_2010_53
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-18064-4
Online ISBN: 978-3-642-18065-1
eBook Packages: EngineeringEngineering (R0)